Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 29CNS 1Breast 1

Conditions

Brain Neoplasms 24Melanoma 19Glioblastoma 13Neuroblastoma 6Glioma 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Transitional Cell 3Carcinoma, Renal Cell 3Wilms Tumor 2Seminoma 2Rhabdomyosarcoma 2Osteosarcoma 2Neoplasm Metastasis 2Meningioma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Hodgkin Disease 2Gliosarcoma 2Central Nervous System Neoplasms 2Astrocytoma 2Xeroderma Pigmentosum 1Vulvar Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1

Interventions

pembrolizumab 2Radiosurgery 2Cyclophosphamide 2pentetreotide 1fludarabine phosphate 1entinostat 1Thrombopoietin 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1LY2940680 1Ipilimumab 1Interleukin-13 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1Filgrastim 1Etoposide 1Cryosurgery 1Carboplatin 1CTLA-4 Antigen 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Ipilimumab × CNS × Clear all
NCT05341349 2026-04-23

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Emory University

Phase 1 Terminated
1 enrolled
CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡